The 13 states where Medicaid covers GLP-1 drugs for obesity are California, Kansas, Minnesota, Wisconsin, Michigan, Mississippi, Pennsylvania, Virginia, North Carolina, Massachusetts, New Hampshire, Delaware and Rhode Island
No differences were observed in energy expenditure or activity (Extended Data Fig
Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors
The feeding medium was continuously added into the bioreactor to obtain a constant specific growth rate (0.25 0.02 h 1 ) after the initial glucose in the medium was completely consumed
It is accessible, easy to see, and offers plenty of real estate to rotate your spots
It is likely that many such systems have relatively low capacities, although they may play crucial site-specific or conditional roles